RS11613331 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:Blood metabolite levels]"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Metabolite levels (deoxycarnitine; butyrobetaine) | A | OR: 0.31 | 1E-100 | PubMed |
| Metabolite levels (1-methylimidazoleacetate; 1-methyl-4-imidazoleacetate; methylimidazoleacetic acid) | A | OR: 0.3 | 7E-80 | PubMed |
| Pyroglutamine levels | A | OR: 0.18 | 4E-68 | PubMed |
| Height | A | β: 0.008 | 2E-35 | PubMed |
| Urine 3-aminoisobutyrate levels in chronic kidney disease | A | OR: 0.38 | 4E-34 | PubMed |
| Metabolite levels (imidazole lactate; imidazolelactate) | A | OR: 0.19 | 3E-29 | PubMed |
| Metabolite levels (Pyroglutamine) | A | OR: 0.18 | 1E-28 | PubMed |
| Pyroglutamine levels | A | β: 0.037 | 2E-25 | PubMed |
| 1-ribosyl-imidazoleacetate levels | A | OR: 0.15 | 8E-25 | PubMed |
| Metabolite levels (3-aminoisobutyrate; __Aminoisobutyrate) | A | OR: 0.16 | 4E-17 | PubMed |
| Serum metabolite levels | G | OR: 0.2 | 5E-17 | PubMed |
| Imidazole propionate levels | A | OR: 0.13 | 1E-16 | PubMed |
| Urinary metabolite levels in chronic kidney disease | G | OR: 0.45 | 5E-15 | PubMed |
| Pyroglutamine levels | A | OR: 0.14 | 2E-14 | PubMed |
| Metabolite levels | — | OR: 0.23 | 2E-12 | PubMed |
| 3-hydroxybutyrate + 3-aminoisobutyrate levels | G | OR: 0.32 | 3E-12 | PubMed |
| Beta-aminoisobutyric acid levels | A | OR: 0.17 | 6E-12 | PubMed |
| Deoxycarnitine levels in elite athletes | — | OR: 0.39 | 2E-11 | PubMed |
| Creatinine levels | — | — | 3E-10 | PubMed |
| 1-methylimidazoleacetate levels in elite athletes | — | OR: 0.3 | 7E-6 | PubMed |